Showing results (421-430 of 501) with videos related to

Sort By:
Pageof 51
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2004
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancerWilliam K Oh, Philip W Kantoff, Vivian Weinberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumorsB Shan, J C Medina, E Santha, et al.
Journal of the American Academy of Dermatology|January 9, 2018
Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapyMaria Estela Martinez-Escala, Alba L Posligua, Heather Wickless, et al.
Blood|June 24, 2008
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomasNancy J Senff, Evert M Noordijk, Youn H Kim, et al.
Science Advances|October 10, 2025
Attention to quantum complexityHyejin Kim, Yiqing Zhou, Yichen Xu, et al.
Nature|July 19, 2019
Signatures of tunable superconductivity in a trilayer graphene moiré superlatticeGuorui Chen, Aaron L Sharpe, Patrick Gallagher, et al.
The Journal of Investigative Dermatology|November 14, 2021
MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell LymphomaZhen Han, Renee J Estephan, Xiwei Wu, et al.
Cancers|February 11, 2023
COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the OutcomeSyed Rahmanuddin, Asma Jamil, Ammar Chaudhry, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Sulfinyl Aziridines as Stereoselective Covalent Destabilizing Degraders of the Oncogenic Transcription Factor MYCHannah T Rosen, Kelvin Li, Erin L Li, et al.
Plos One|September 25, 2024
A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseasesCharles L Bennett, Joseph Magagnoli, Krishna Gundabolu, et al.
Pageof 51